fbpx Skip to main content


Jeffrey Stoddard, M.D.



As Vice President, Medical Affairs, Jeffrey Stoddard, M.D., is responsible for leading Janssen’s medical affairs efforts for the entirety of the Infectious Diseases & Vaccines portfolio, partnering closely with the Commercial and R&D leaders, and the full cross-functional team.

Jeff joined the Johnson & Johnson Family of Companies from GSK Vaccines where he was US Medical Affairs Lead, Zoster, and was instrumental in all aspects of the medical, commercial and late stage development launch workstreams related to the company’s shingles vaccine from 2017 through 2019. His expertise ranges across vaccines (viral and bacterial, pediatric and adult), biologics, and small molecules. He has advised national governments regarding vaccine policy and has worked extensively in the R&D stages within the biopharmaceutical industry, as well as commercial strategy from pre-launch planning to launch execution.

Prior to GSK, Jeff worked at Novavax, where his work focused on older adult and maternal respiratory syncytial virus (RSV) vaccine development. He also worked in academic and policy research roles and served as Vice President and Global Head of Medical Affairs at Novartis Vaccines. He has authored more than 70 peer-reviewed journal articles, and four chapters in medical textbooks.

Jeff is a graduate of the University of Wisconsin Medical School, completed a residency at the Johns Hopkins Hospital in Baltimore, and completed a postdoctoral fellowship at the University of California-San Francisco. He is a board-certified pediatrician with advanced postdoctoral training in health policy.